Pfizer's Zoetis (ZTS) Sees IPO Price of $22 - $25/Share

Article Related Articles (1) Stock Quotes (2) Comments (0)

Zoetis Inc. (NYSE: ZTS) filed an amended registration with the U.S. SEC for an Initial Public Offering of its Common Stock. The Company plans to sell 86.1 million shares and sees and offering price of $22 to $25 per share. The Company filed to list on the New York Stock Exchange under the ticker, "ZTS."

Underwriters on the offering are J.P. Morgan, BofA Merrill Lynch, Morgan Stanley, Barclays, Citigroup, Credit Suisse, Deutsche Bank Securities, Goldman, Sachs & Co., Guggenheim Securities, Jefferies, BNP PARIBAS, HSBC, Loop Capital Markets, RBC Capital Markets, The Williams Capital Group, L.P., UBS Investment Bank, Lebenthal Capital Markets, Piper Jaffray, and Ramirez & Co., Inc.

Zoetis was an animal health subsidiary of Pfizer Inc. (NYSE: PFE).

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Zoetis (ZTS) to S&P 500; First Horizon (FHN) to S&P MidCap 400
• Russia's Lenta Said to Select Bankers for Massive IPO - Reuters
• Zoetis Set to Join S&P 500; First Horizon National to Join S&P MidCap 400; QLogic to Join S&P SmallCap 600

Create E-mail Alert Related Categories

IPOs

Related Entities

Credit Suisse, Piper Jaffray, Deutsche Bank, UBS, JPMorgan, Citi, Morgan Stanley, Jefferies & Co, Merrill Lynch, Bank of America, RBC Capital, Barclays, HSBC

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?